Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Graefe's Archive for Clinical and Experimental Ophthalmology
Literature
1.
Li X, Wang N, Liang X et al (2018) Safety and efficacy of dexamethasone intravitreal implant for treatment of macular edema secondary to retinal vein occlusion in Chinese patients: randomized, sham-controlled, multicenter study. Graefes Arch Clin Exp Ophthalmol 256:59–69CrossRefPubMed
2.
Călugăru D, Călugăru M (2016) Retinal vein occlusion and the use of a dexamethasone intravitreal implant (Ozurdex) in its treatment. Graefes Arch Clin Exp Ophthalmol 254:2477–2478CrossRefPubMed
3.
Călugăru D, Călugăru M (2017) Baseline choroidal thickness as a predictor for treatment outcomes in central retinal vein occlusion. Am J Ophthalmol 176:257–258PubMedCrossRef
4.
Călugăru D, Călugăru M (2017) Disorganization of the retinal inner layers as a predictor of visual acuity in eyes with macular edema secondary to vein occlusion. Am J Ophthalmol 184:190–191CrossRefPubMed
5.
Kuppermann BD, Haller JA, Bandello F (2014) Onset and duration of visual acuity improvement after dexamethasone intravitreal implant in eyes with macula edema due to retinal vein occlusion. Retina 34:1743–1749CrossRefPubMed
6.
Călugăru D, Călugăru M (2017) Dexamethasone intravitreal implant in retinal vein occlusion: real-life data from a prospective, multicenter clinical trial. Graefes Arch Clin Exp Ophthalmol 255:427–428CrossRefPubMed
7.
Călugăru D, Călugăru M (2017) Two-year, prospective, multicenter study of the use of dexamethasone intravitreal implant for treatment of macular edema secondary to retinal vein occlusion in the clinical setting in France. Graefes Arch Clin Exp Ophthalmol 255:211–212CrossRefPubMed
8.
Călugăru D, Călugăru M (2015) Intravitreal bevacixumab in acute central/hemicentral retinal vein occlusions: three-year results of a prospective clinical study. J Ocul Pharmacol Ther 31:78–86CrossRefPubMed
9.
Călugăru D, Călugăru M (2017) Ranibizumab for retinal vein occlusion. Predictive factors and long-term outcomes in real-life data Retina 37:e84–e86
10.
Călugăru D, Călugăru M, Yeh RE et al (2015) Ophthalmic technology assessment: Therapies for macular edema associated with central retinal vein occlusion: A report by the American Academy of Ophthalmology. Ophthalmology 122:e65–e66CrossRefPubMed
Metadata
Title
Safety and efficacy of dexamethasone intravitreal implant for treatment of macular edema secondary to retinal vein occlusion in Chinese patients: randomized, sham-controlled, multicenter study
Authors
Dan Călugăru
Mihai Călugăru
Publication date
01-06-2018
Publisher
Springer Berlin Heidelberg
Published in
Graefe's Archive for Clinical and Experimental Ophthalmology / Issue 6/2018
Print ISSN: 0721-832X
Electronic ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-018-3918-8

Other articles of this Issue 6/2018

Graefe's Archive for Clinical and Experimental Ophthalmology 6/2018 Go to the issue

Basic Science

Tear film proteome in age-related macular degeneration

Book Review

OCT Angiography OCT Angiography (2017) by Chow, de Oliveira et al., 190 pp., 161 illustrations, €89.99/$99.99 Hardback ISBN: 9781626234734 Thieme Publishers New York/Stuttgart

Retinal Disorders

Long-term follow-up of lamellar macular holes and pseudoholes over at least 5 years

Oculoplastics and Orbit

Autoantibody against aldehyde dehydrogenase 2 could be a biomarker to monitor progression of Graves’ orbitopathy

Editorial

The legacy of Jules Gonin: one hundred years of identifying and treating retinal breaks

Retinal Disorders

The reactivation time in the treatment of AMD: a forgotten key parameter?